文献速递自身免疫性与大疱性皮肤病

皮肌炎合并恶性肿瘤:宾夕法尼亚大学201例回顾性研究

Malignancy in dermatomyositis: A retrospective study of 201 patients seen at the University of Pennsylvania.
PubMed 文献 · J Am Acad Dermatol · 2020-03-02

该回顾性队列研究纳入2008年7月至2018年4月在宾夕法尼亚大学门诊皮肤科前瞻性登记的201例成人起病皮肌炎患者,比较经典型与临床无肌病型皮肌炎合并恶性肿瘤的患病率,并分析相关危险因素。结果显示诊断后2年内经典型和临床无肌病型皮肌炎合并恶性肿瘤的患病率分别为9.9%和1.7%;多变量回归分析中,诊断时年龄较大(P = .01)和经典型亚型(P = .04)与 underlying malignancy 显著相关。结论认为年龄较大和经典型皮肌炎是皮肌炎发病2年内合并恶性肿瘤的独立危险因素。

要点

  • 经典型皮肌炎诊断后2年内恶性肿瘤患病率为9.9%,临床无肌病型为1.7%。
  • 诊断时年龄较大和经典型亚型是2年内合并恶性肿瘤的独立危险因素。
  • 临床需对年龄较大及经典型皮肌炎患者加强恶性肿瘤筛查。

核心结论

  • 年龄较大和经典型皮肌炎是皮肌炎发病2年内合并恶性肿瘤的独立危险因素。

研究设计与样本

  • 回顾性队列研究,纳入2008年7月至2018年4月在宾夕法尼亚大学门诊皮肤科前瞻性登记的201例成人起病皮肌炎患者。

主要发现

  • 201例中经典型142例(71%),临床无肌病型59例(29%)。
  • 诊断后2年内经典型和临床无肌病型皮肌炎合并恶性肿瘤的患病率分别为9.9%和1.7%。
  • 多变量回归分析显示诊断时年龄较大(P = .01)和经典型亚型(P = .04)与 underlying malignancy 显著相关。

临床怎么用

  • 对年龄较大和经典型皮肌炎患者,应在发病2年内加强恶性肿瘤筛查。

局限性

  • 回顾性研究,数据来自单中心前瞻性收集的登记队列。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: There is an increased incidence of malignancy in patients with dermatomyositis. It is unknown if the risk differs between the subtypes of dermatomyositis. OBJECTIVE: To (1) compare the prevalence of malignancy-associated dermatomyositis between patients with classic and clinically amyopathic disease and (2) determine factors associated with an increased risk of malignancy-associated disease. METHODS: Retrospective cohort study of 201 patients with adult-onset dermatomyositis prospectively enrolled in a longitudinal dermatomyositis database between July 2008 and April 2018 at an outpatient dermatology urban tertiary referral center. The main outcome measure was a diagnosis of malignancy, excluding nonmelanoma skin cancer. RESULTS: There were 201 patients with adult-onset dermatomyositis: 142 (71%) classic and 59 (29%) clinically amyopathic. Within 2 years of diagnosis, the prevalences of malignancy-associated classic and clinically amyopathic dermatomyositis were 9.9% and 1.7%, respectively. In this time period, patients who were older at dermatomyositis diagnosis (P = .01) and had the classic subtype (P = .04) were significantly more likely to have an underlying malignancy on multivariable regression analysis. LIMITATIONS: This was a retrospective study of prospectively collected data at a single tertiary referral center. CONCLUSION: Older age and classic dermatomyositis are independent risk factors for malignancy-associated dermatomyositis within 2 years of disease onset.

来源:J Am Acad Dermatol,查看原文。版权归原作者所有。

引用

  1. Bowerman K, Pearson DR, Okawa J, et al. Malignancy in dermatomyositis: A retrospective study of 201 patients seen at the University of Pennsylvania. J Am Acad Dermatol. 2020. PMID: 32135206. doi:10.1016/j.jaad.2020.02.061

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。